Globus Medical (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2017.

As quoted in the press release:

• Worldwide sales increased 16.1% as reported to $176.0 million
• Fourth quarter net income was $24.4 million, or 13.8% of sales, including a one-time tax reform expense of $11.0 million
• Diluted earnings per share (EPS) were $0.25
• Non-GAAP diluted EPS were $0.38
• Non-GAAP adjusted EBITDA was 34.9% of sales

Click here to read the full press release.